Cardiovascular disease in haemodialysis and peritoneal dialysis: Arguments pro peritoneal dialysis

Nephrology Dialysis Transplantation

Volumn 22, Issue 1, 2007, Pages 53-58

  Van Biesen, Wim ^a   Verbeke, Francio ^a   Vanholder, Raymond ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Cardiovascular; Hemodialysis; Outcome; Peritoneal dialysis; Survival; Uraemic toxins

Indexed keywords

DIURETIC AGENT; ICODEXTRIN;

ARTICLE; BRAIN HEMORRHAGE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY DISEASE; CONGESTIVE HEART FAILURE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; HEART CATHETERIZATION; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEMODIALYSIS; HEMOFILTRATION; HUMAN; HYPERTENSION; INFLAMMATION; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; KIDNEY FUNCTION; MORTALITY; OUTCOMES RESEARCH; PERITONEAL DIALYSIS; PRIORITY JOURNAL; RISK ASSESSMENT; SODIUM RESTRICTION; SURVIVAL RATE;

CARDIOVASCULAR DISEASES; HEART FAILURE, CONGESTIVE; HUMANS; INFLAMMATION; KIDNEY FAILURE, CHRONIC; PERITONEAL DIALYSIS; PREVALENCE; RENAL DIALYSIS; RISK; RISK FACTORS; TREATMENT OUTCOME; UREMIA;

EID: 33846010502     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl601     Document Type: Article

References (63)

1. Harnett JD, Foley RN, Kent GM et al. Congestive heart failure in dialysis patients: Prevalence, incidence, prognosis and risk factors. Kidney Int 1995; 47: 884-890
2. Parfrey PS, Foley RN, Harnett JD et al. Outcome and risk factors of ischemic heart disease in chronic uremia. Kidney Int 1996; 49: 1428-1434
3. Best PJ, Holmes DR,Jr. Chronic kidney disease as a cardiovascular risk factor. Am Heart J 2003; 145: 383-386
4. O'Hare AM, Hsu CY, Bacchetti P, Johansen KL. Peripheral vascular disease risk factors among patients undergoing hemodialysis. J Am Soc Nephrol 2002; 13: 497-503
5. Mattana J, Effiong C, Gooneratne R, Singhal PC. Risk of fatal cerebrovascular accident in patients on peritoneal dialysis versus hemodialysis. J Am Soc Nephrol 1997; 8: 1342-1347
6. Ganesh SK, Hulbert-Shearon T, Port FK, Eagle K, Stack AG. Mortality differences by dialysis modality among incident ESRD patients with and without coronary artery disease. J Am Soc Nephrol 2003; 14: 415-424
7. Stack AG, Molony DA, Rahman NS, Dosekun A, Murthy B. Impact of dialysis modality on survival of new ESRD patients with congestive heart failure in the United States. Kidney Int 2003; 64: 1071-1079
8. Fenton SS, Schaubel DE, Desmeules M et al. Hemodialysis versus peritoneal dialysis: A comparison of adjusted mortality rates. Am J Kidney Dis 1997; 30: 334-342
9. Heaf JG, Lokkegaard H, Madsen M. Initial survival advantage of peritoneal dialysis relative to haemodialysis. Nephrol Dial Transplant 2002; 17: 112-117
10. Termorshuizen F, Korevaar JC, Dekker FW et al. Hemodialysis and peritoneal dialysis: Comparison of adjusted mortality rates according to the duration of dialysis: Analysis of The Netherlands Cooperative Study on the Adequacy of Dialysis 2. J Am Soc Nephrol 2003; 14: 2851-2860
11. Van Biesen W, Vanholder RC, Veys N, Dhondt A, Lameire NH. An evaluation of an integrative care approach for end-stage renal disease patients. J Am Soc Nephrol 2000; 11: 116-125
12. Bloembergen WE, Port FK, Mauger EA, Wolfe RA. A comparison of cause of death between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol 1995; 6: 184-191
13. Stack AG, Murthy BV, Molony DA. Survival differences between peritoneal dialysis and hemodialysis among "large" ESRD patients in the United States. Kidney Int 2004; 65: 2398-2408
14. Vonesh EF, Moran J. Mortality in end-stage renal disease: A reassessment of differences between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol 1999; 10: 354-365
15. Locatelli F, Marcelli D, Conte F et al. Survival and development of cardiovascular disease by modality of treatment in patients with end-stage renal disease. J Am Soc Nephrol 2001; 12: 2411-2417
16. Foley RN, Parfrey PS, Harnett JD et al. Mode of dialysis therapy and mortality in end-stage renal disease. J Am Soc Nephrol 1998; 9: 267-276
17. Trespalacios FC, Taylor AJ, Agodoa LY, Bakris GL, Abbott KC. Heart failure as a cause for hospitalization in chronic dialysis patients. Am J Kidney Dis 2003; 41: 1267-1277
18. Trespalacios FC, Taylor AJ, Agodoa LY, Bakris GL, Abbott KC. Heart failure as a cause for hospitalization in chronic dialysis patients. Am J Kidney Dis 2003; 41: 1267-1277
19. Vonesh EF, Snyder JJ, Foley RN, Collins AJ. The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis. Kidney Int 2004; 66: 2389-2401
20. Collins AJ, Kasiske B, Herzog C et al. Excerpts from the United States Renal Data System 2004 annual data report: Atlas of end-stage renal disease in the United States. Am J Kidney Dis 2005; 45: A5-A7
21. Iseki K, Kinjo K, Kimura Y, Osawa A, Fukiyama K. Evidence for high risk of cerebral hemorrhage in chronic dialysis patients. Kidney Int 1993; 44: 1086-1090
22. Fissell RB, Bragg-Gresham JL, Gillespie BW et al. International variation in vitamin prescription and association with mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2004; 44: 293-299
23. Pisoni RL, Greenwood RN. Selected lessons learned from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Contrib Nephrol 2005; 149: 58-68
24. Sigrist M, Bungay P, Taal MW, McIntyre CW. Vascular calcification and cardiovascular function in chronic kidney disease. Nephrol Dial Transplant 2006; 21: 707-714
25. Van Biesen W, Vanholder R, Debacquer D, De Backer G, Lameire N. Comparison of survival on CAPD and haemodialysis: Statistical pitfalls. Nephrol Dial Transplant 2000; 15: 307-311
26. Churchill DN, Thorpe KE, Vonesh EF, Keshaviah PR. Lower probability of patient survival with continuous peritoneal dialysis in the United States compared with Canada. Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol 1997; 8: 965-971
27. Guo A, Mujais S. Patient and technique survival on peritoneal dialysis in the United States: Evaluation in large incident cohorts. Kidney Int Suppl 2003; S3-S12
28. Stack AG, Saran R. Clinical correlates and mortality impact of left ventricular hypertrophy among new ESRD patients in the United States. Am J Kidney Dis 2002; 40: 1202-1210
29. Glorieux GL, Dhondt AW, Jacobs P et al. In vitro study of the potential role of guanidines in leukocyte functions related to atherogenesis and infection. Kidney Int 2004; 65: 2184-2192
30. Vanholder R, Glorieux G, Lameire N. Uraemic toxins and cardiovascular disease. Nephrol Dial Transplant 2003; 18: 463-466
31. Culleton BF, Larson MG, Wilson PW et al. Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int 1999; 56: 2214-2219
32. Eloot S, Torremans A, De Smet R et al. Kinetic behavior of urea is different from that of other water-soluble compounds: The case of the guanidino compounds. Kidney Int 2005; 67: 1566-1575
33. Jankowski J, Hagemann J, Yoon MS et al. Increased vascular growth in hemodialysis patients induced by platelet-derived diadenosine polyphosphates. Kidney Int 2001; 59: 1134-1141
34. Jankowski V, Tolle M, Vanholder R et al. Uridine adenosine tetraphosphate: A novel endothelium-derived vasoconstrictive factor. Nat Med 2005; 11: 223-227
35. Cheung AK, Levin NW, Greene T et al. Effects of high-flux hemodialysis on clinical outcomes: Results of the HEMO study. J Am Soc Nephrol 2003; 14: 3251-3263
36. Jansen MA, Hart AA, Korevaar JC et al. Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int 2002; 62: 1046-1053
37. McKane W, Chandna SM, Tattersall JE, Greenwood RN, Farrington K. Identical decline of residual renal function in high-flux biocompatible hemodialysis and CAPD. Kidney Int 2002; 61: 256-265
38. Bleyer AJ, Russell GB, Satko SG. Sudden and cardiac death rates in hemodialysis patients. Kidney Int 1999; 55: 1553-1559
39. Stewart GA, Gansevoort RT, Mark PB et al. Electrocardiographic abnormalities and uremic cardiomyopathy. Kidney Int 2005; 67: 217-226
40. Wang AY, Wang M, Woo J et al. A novel association between residual renal function and left ventricular hypertrophy in peritoneal dialysis patients. Kidney Int 2002; 62: 639-647
41. Lameire N, Bernaert P, Lambert MC, Vijt D. Cardiovascular risk factors and their management in patients on continuous ambulatory peritoneal dialysis. Kidney Int Suppl 1994; 48: S31-S38
42. Enia G, Mallamaci F, Benedetto FA et al. Long-term CAPD patients are volume expanded and display more severe left ventricular hypertrophy than haemodialysis patients. Nephrol Dial Transplant 2001; 16: 1459-1464
43. Stewart GA, Foster J, Cowan M et al. Echocardiography overestimates left ventricular mass in hemodialysis patients relative to magnetic resonance imaging. Kidney Int 1999; 56: 2248-2253
44. Tonbul Z, Altintepe L, Sozlu C, Yeksan M, Yildiz A, Turk S. Ambulatory blood press ure monitoring in haemodialysis and continuous ambulatory peritoneal dialysis patients. J Hum Hypertens 2002; 16: 585-589
45. Gunal AI, Duman S, Ozkahya M et al. Strict volume control normalizes hypertension in peritoneal dialysis patients. Am J Kidney Dis 2001; 37: 588-593
46. Gunal AI, Ilkay E, Kirciman E et al. Blood pressure control and left ventricular hypertrophy in long-term CAPD and hemodialysis patients: A cross-sectional study. Perit Dial Int 2003; 23: 563-567
47. Medcalf JF, Harris KP, Walls J. Role of diuretics in the preservation of residual renal function in patients on continuous ambulatory peritoneal dialysis. Kidney Int 2001; 59: 1128-1133
48. Davies SJ, Woodrow G, Donovan K et al. Icodextrin improves the fluid status of peritoneal dialysis patients: Results of a double-blind randomized controlled trial. J Am Soc Nephrol 2003; 14: 2338-2344
49. Konings CJ, Kooman JP, Schonck M et al. Effect of icodextrin on volume status, blood pressure and echocardiographic parameters: A randomized study. Kidney Int 2003; 63: 1556-1563
50. Wang AM, Lam CK, Yu CM et al. Troponin T, left ventricular mass, and function are excellent predictors of cardiovascular congestion in peritoneal dialysis. Kidney Int [Epub ahead of print 28 June 2006]
51. Rodriguez-Carmona A, Perez-Fontan M, Garca-Naveiro R, Villaverde P, Peteiro J. Compared time profiles of ultrafiltration, sodium removal, and renal function in incident CAPD and automated peritoneal dialysis patients. Am J Kidney Dis 2004; 44: 132-145
52. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105: 1135-1143
53. Stenvinkel P, Heimburger O, Paultre F et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 1999; 55: 1899-1911
54. Ishani A, Collins AJ, Herzog CA, Foley RN. Septicemia, access and cardiovascular disease in dialysis patients: The USRDS Wave 2 study. Kidney Int 2005; 68: 311-318
55. Fusshoeller A, Plail M, Grabensee B, Plum J. Biocompatibility pattern of a bicarbonate/lactate-buffered peritoneal dialysis fluid in APD: A prospective, randomized study. Nephrol Dial Transplant 2004; 19: 2101-2106
56. Zeier M, Schwenger V, Deppisch R et al. lucose degradation products in PD fluids: Do they disappear from the peritoneal cavity and enter the systemic circulation? Kidney Int 2003; 63: 298-305
57. Pecoits-Filho R, Heimburger O, Barany P et al. Associations between circulating inflammatory markers and residual renal function in CRF patients. Am J Kidney Dis 2003; 41: 1212-1218
58. Vanholder R, Massy Z, Argiles A et al. Chronic kidney disease as cause of cardiovascular morbidity and mortality. Nephrol Dial Transplant 2005
59. Stack AG, Serna H, Ramsanahie A, Henry C. Determinants and prognostic importance of cardiomegaly among new ESRD patients in the United States. Ann Epidemiol 2004; 14: 676-685
60. Kronenberg F, Lingenhel A, Neyer U et al. Prevalence of dyslipidemic risk factors in hemodialysis and CAPD patients. Kidney Int Suppl 2003; S113-S116
61. Yilmaz FM, Yilmaz G, Duranay M et al. Cardiovascular risk factors in hemodialysis and peritoneal dialysis patients. Scand J Clin Lab Invest 2005; 65: 739-745
62. Habib AN, Baird BC, Leypoldt JK, Cheung AK, Goldfarb-Rumyantzev AS. The association of lipid levels with mortality in patients on chronic peritoneal dialysis. Nephrol Dial Transplant 2006; 21: 2881-2892
63. Foley RN, Herzog CA, Collins AJ. Smoking and cardiovascular outcomes in dialysis patients: The United States Renal Data System Wave 2 study. Kidney Int 2003; 63: 1462-1467